Dr Reddys Laboratories (RDY) Net Cash Flow (2009 - 2018)

Dr Reddys Laboratories (RDY) has reported Net Cash Flow for 9 consecutive years, with -$1.7 billion the latest figure, recorded in Q1 2018.

• Quarterly Net Cash Flow changed N/A year-over-year to -$1.7 billion in Q1 2018, while the trailing twelve-month figure through Dec 2018 was -$1.7 billion (down 644.12% YoY) and the FY2026 annual result came in at -$5.0 million, down 105.88% from the prior year.
• Net Cash Flow eased to -$1.7 billion in Q1 2018 per RDY's latest filing, from $2.2 billion in the prior quarter.
• Over the last five years, Net Cash Flow for RDY reached as high as $19.5 billion in Q3 2016 and fell as low as -$9.4 billion in Q3 2015.
• A 4-year average of -$150.1 million and a median of -$2.6 billion in 2015 frame the typical range for Net Cash Flow.
• Annual changes were most pronounced in 2016 — Net Cash Flow surged 307.35% — and 2017, when it tumbled 109.93%.
• Year by year, Net Cash Flow stood at -$3.3 billion in 2015, then dropped by 8.04% to -$3.5 billion in 2016, then soared by 163.72% to $2.2 billion in 2017, then slumped by 174.23% to -$1.7 billion in 2018.
• According to Business Quant data, Net Cash Flow over the past three periods registered -$1.7 billion, $2.2 billion, and -$1.9 billion for Q1 2018, Q4 2017, and Q3 2017 respectively.